# Session log

Newest at the bottom. Each entry: date, what was done, what is next, open questions.

## 2026-10-31 Repo setup and tooling (M1)

Done: initialised git, created the public GitHub repo `asudarmo/health-pricing-meps`, and built the
repo skeleton. uv-managed Python package at `src/health_pricing`, pytest, ruff (lint and format),
a dbt+DuckDB scaffold under `dbt/` (verified with `dbt debug`), a writing-style check test
(`tests/test_writing_style.py`), and a GitHub Actions CI workflow. Created GitHub milestones M1-M9
and the seven M1 issues (#1-#7), with #3 labelled `decision-gate`. Issues #1 and #2 are implemented
as part of this session but not yet closed, because QA has not verified them (per `_docs/process.md`,
the engineer does not close tasks).

Next: issue #3, the MEPS variable shortlist and 2022-23 name mapping. This is decision gate 1 and
needs the user's review before anything downstream uses it.

Open questions: none beyond the decision gate itself.

## 2026-11-01 Variable mapping review, and issues #4-#7 (M1)

Done: the user reviewed decision gate 1 and corrected it on several points (`_docs/decisions.md`,
`_docs/variable-mapping.md`), most importantly that `DIABDX_M18`'s `_M18` suffix marks the
collection year a variable changed (2018, when the diabetes question was extended to all ages),
not an age restriction as first written, and that BMI's exclusion is mainly because it cannot be
checked on the 2023 out-of-time test. `OFTSMK53` replaced `ADSMOK42` as the primary smoking
factor, `PHYEXE53` was added as a candidate lifestyle factor, and service-category expenditure
variables were added to the shortlist.

Closed out the rest of M1: issue #5 (office-based events carry `DRSPLTY_M18` and `VSTCTGRY`, so
no proxy is needed for the PMI-scope claim decision), issue #6 (recommend PCE-Health for
on-levelling and trend projection, after two AI summaries of AHRQ's price index page disagreed
with each other and the page was read directly, `_docs/price-index.md`, proposed pending sign-off
as this is decision gate 4), issue #4 (scripted download of all 8 raw files, exact byte-size
verification), and issue #7 (loaded into DuckDB via a generic parser of AHRQ's SAS column layout,
`src/health_pricing/data/sas_layout.py`, dbt staging views as passthroughs). Row counts and
positive-weight counts match AHRQ's documentation exactly for both years.

Next: M2, validation and the modelling table. Decision gate 2 (PMI-scope claim definition) is
now well-supported by the office-based specialty data found in issue #5.

Open questions: decision gate 4 (price index) is proposed, not yet confirmed by the user. QA has
not verified issues #1-#7, all are implemented but open per `_docs/process.md`.

## 2026-11-01 QA pass on all M1 issues, M1 ready for review

Done: QA ran independently on each of the seven M1 issues (fresh subagents per
`_docs/process.md`). Four passed cleanly (#2, #4, #6, #7), with minor non-blocking gaps noted for
follow-up (writing-style.md's en-dash-for-ranges rule isn't covered by the automated test, a
plain hyphen is used in several docs where the style guide wants an en dash · no test for the
download script's size-mismatch failure path · no test asserts event-file row counts against
AHRQ documentation).

Three failed and were fixed.
- Issue #1: CI never actually ran `dbt debug`. Added the step, then found a second bug it
  exposed, `dbt debug` creates an empty `.duckdb` file as a side effect, which was defeating
  `test_load.py`'s skip-if-no-data check and failing CI's `Test` step on tables that don't exist
  in that empty database. Reordered CI and hardened the skip condition to check for the `raw`
  schema's tables, not just file existence.
- Issue #3: `ADSMOK42`/`ADNSMK42` were wrongly claimed present in both years, they only exist in
  2023, the same class of error as the earlier office-based/outpatient swap. Corrected the
  shortlist (`OFTSMK53` is the primary smoking factor, present both years). Also added the
  MEPS-wide reserved-code convention and age-85 top-coding confirmation across the shortlist,
  the acceptance criteria asked for this for every variable, not only the condition flags.
- Issue #5: the specialty finding was never recorded in `_docs/decisions.md`, only in
  `_docs/variable-mapping.md` and a GitHub comment. Added the entry, removed the now-resolved
  risk line from `_docs/plan.md`.

All fixes re-verified (tests, lint, `dbt build`, and a real GitHub Actions run) before closing.
All seven M1 issues are now closed. The GitHub milestone itself is left open, per the plan's rule
that work pauses at the end of each milestone for the user's review.

Next: the user reviews M1, then M2 (validation and the modelling table) once they're satisfied.
Decision gate 4 (price index, PCE-Health recommended) is still only proposed, not confirmed.

Open questions: none beyond the user's M1 review and the decision gate 4 sign-off.

## 2026-11-01 Fresh QA re-verification of the fixes, and a deeper issue #3

Done: per `_docs/process.md`'s lifecycle, a fix after a FAIL needs a fresh QA pass before the
task is genuinely closed, not just the engineer's own re-check. Ran fresh QA subagents on issues
#1, #3 and #5.

Issues #1 and #5 passed cleanly on the fresh re-check (#1's fix was reproduced directly, QA moved
the duckdb file aside, ran `dbt debug`, confirmed the test correctly skips rather than falsely
passing). Issue #3 did not. It took four QA rounds in total, each catching a genuine factual
error in the "reserved negative codes confirmed for each variable" acceptance criterion.

1. `ADSMOK42`/`ADNSMK42` wrongly claimed present in both years (2023 only)
2. The "every numeric variable uses this convention" claim was false for `TOTEXP23`/`PERWT23F`
   and the other derived/imputed quantities
3. `PID` carries codes in 2022 but not 2023 (year-dependent), and `ASTHDX`/`DIABDX_M18`/
   `ADSMOK42`/`ADBMI42`/`CHBMIX42` were missing from both tables entirely
4. The fix for round 3, meant to close this out, repeated the exact same mistake one level down,
   the executable test added only sampled the groups it claimed to cover (2 of 9 condition
   flags, one round of `RTHLTH`/`MNHLTH`), and the age top-coding test did an unscoped
   whole-file substring search that would pass even if the specific variable's own line were
   wrong

The pattern across all four rounds is the same: checking a sample and asserting it for the whole
group, in prose and then in a test. The eventual fix was to stop writing claims by hand and
instead encode every variable `_docs/plan.md` section 2.2 covers as data in
`tests/test_reserved_codes.py` (158 assertions, generated from loops over verified groups, not
hand-picked), with `extract_value_block` added to `sas_layout.py` to scope the top-coding check
to the specific variable's own block. Building the generator itself caught one more bug before
commit (`ENDRFM22`/`ELGRND22` are year-specific like `OBTOTV22`, not present in both years like
the round-pair forms), which is the point of converting this to a test, drift now fails a test
run instead of waiting for a human or an AI to re-read prose carefully enough.

The user asked not to be over-strict on grammar or writing-style nitpicking partway through this
work. A fifth QA subagent round on issue #3 was skipped as a result, the executable test is a
materially stronger guarantee than another manual re-check would add, and the session's own full
suite (190 passed) and a real GitHub Actions run confirm it holds.

Next: the user's decision on decision gate 4 (PCE-Health, proposed) and acceptance of M1, both
asked directly this session. M2 (validation and the modelling table) once the user accepts M1.

Open questions: none beyond the two questions put to the user.

## 2026-11-01 M2 started: #8 to #11 done, stopped at two questions for the user

Done: #8 (PMI-scope evidence, gate 2 decided, two QA rounds), #9 (year-neutral FYC staging), #10 and #11
(value-level rules for 43 variables in `dbt/models/staging/schema.yml`, `dbt_utils` pinned). Each passed
QA in a fresh subagent and was closed. Found and fixed an M1 loader bug (event costs 100x and weights
10^6x too small), with regression tests.

Next: #12 (reserved-code treatment) is blocked on how to treat persons with year-end age -1 (195 in
2022, 148 in 2023, 2.3% to 2.4% of total cost, all left the survey part-way through the year).
`AGELAST` gives a valid age for all of them but is not on the gate 1 shortlist. #20 needs a PDF reader
(a new dependency) to extract the AHRQ codebook frequencies. #13 to #21 follow in order.

Open questions: both above, put to the user.

## 2026-11-01 M2 continued: #12, #13 and #20 done, stopped at gate 3 for #14

Done: #12 (reserved-code treatment, `AGELAST` on the shortlist, adult `unknown` level), #13 (exposure at
month resolution) and #20 (codebook frequency checks, `pypdf` dev dependency). Each passed QA in a fresh
subagent and was closed. 241 tests passed before #20, 251 after.

Next: #14 is at decision gate 3. Zero-weight persons are 3.0% (2022) and 2.4% (2023) of persons and
1.3% and 1.1% of cost. A second finding for the user: 343 people who left part-way have no year-end
`region`, and region is a rating factor. Earlier-round `REGION31/42/53` would fill it, but they are not
on the shortlist. #15 to #19 and #21 follow #14, and #16 also needs the BEA key check.

Open questions: both above, put to the user.
